首页|卵巢肿瘤组织中Wee1蛋白激酶的表达及意义

卵巢肿瘤组织中Wee1蛋白激酶的表达及意义

扫码查看
目的:评估Wee1 蛋白激酶在卵巢肿瘤组织中的表达水平及其临床意义.方法:采用免疫组化染色技术,对包含14 例良性、9 例交界性及36 例恶性卵巢肿瘤组织的组织芯片中Wee1 蛋白激酶表达水平进行检测.采用Kaplan-Meier法绘制Wee1 蛋白激酶高、低表达卵巢恶性肿瘤患者的生存曲线,采用Cox回归分析Wee1 蛋白激酶表达与卵巢恶性肿瘤预后的关联.结果:良性、交界性和恶性卵巢肿瘤组织中Wee1 蛋白激酶表达水平分别为(1.29±0.47)、(2.22±0.83)和(2.03±1.00),3 组比较,差异有统计学意义(P=0.017),恶性和交界性肿瘤组织中Wee1 蛋白激酶表达水平高于良性肿瘤组织(P<0.05).卵巢恶性肿瘤患者中 15 例Wee1 蛋白激酶高表达,21例低表达;Kaplan-Meier生存曲线分析结果显示,高表达组生存状况差于低表达组(P<0.001);Cox回归分析结果显示,Wee1 蛋白激酶高表达者预后差,HR(95%CI)为6.38(1.54~26.52).结论:卵巢恶性肿瘤组织中Wee1 蛋白激酶表达水平高于良性肿瘤组织,且与恶性肿瘤预后有关.
Wee1 protein kinase expression and clinical significance in ovarian tumor tissue
Aim:To evaluate the expression and clinical significance of Wee1 protein kinase in ovarian tumor tissue.Methods:Using immunohistochemistry,Wee1 protein expression level in tissue microarrays including 14 benign,9 border-line,and 36 malignant ovarian tumor tissue samples was detected.Kaplan-Meier survival curves of malignant ovarian tumor patients with high and low expression of Wee1 protein kinase were drawn.Cox regression analysis was employed to examine the association between Wee1 protein kinase expression and the prognosis of malignant ovarian tumors.Results:The expres-sion level of Wee1 protein kinase in benign,borderline,and malignant tumor tissue was(1.29±0.47),(2.22±0.83),and(2.03±1.00),respectively,and there were significant differences among the 3 groups(P=0.017).The expression level of week1 protein kinase in malignant and borderline tumor tissue was higher than that in benign tumor tissue(P<0.05).Among patients with malignant ovarian tumor,15 exhibited high expression and 21 exhibited low expression of Wee1 protein kinase.The high-expression group had worse survival outcomes than the low-expression group(P<0.001).Cox re-gression analysis indicated that high Wee1 protein kinase expression was associated with poor prognosis,with HR(95%CI)of 6.38(1.54-26.52).Conclusion:Wee1 protein kinase expression level may be higher in malignant ovarian tumor tissue compared with benign tumor tissue,and associated with the prognosis of malignant tumors.

ovarian tumortissue microarrayWee1 protein kinase

冯文龙、段震峰、王静璐、史惠蓉

展开 >

郑州大学第一附属医院妇科 郑州 450052

迈阿密大学米勒医学院肉瘤生物学实验室 迈阿密 美国 33136

卵巢肿瘤 组织芯片 Wee1蛋白激酶

国家自然科学基金青年基金项目河南省医学科技攻关计划联合共建项目

8230361771893

2024

郑州大学学报(医学版)
郑州大学

郑州大学学报(医学版)

CSTPCD北大核心
影响因子:1.246
ISSN:1671-6825
年,卷(期):2024.59(5)